Terms: = Skin cancer AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C
34 results:
1. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid cancer Survivors in the United States.
Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
[No Abstract] [Full Text] [Related]
2. Validation of the 2022 National Comprehensive cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma.
Stevens JS; Murad F; Smile TD; O'Connor DM; Ilori E; Koyfman S; Vidimos A; Waldman AB; Ruiz ES
JAMA Dermatol; 2023 Jul; 159(7):728-735. PubMed ID: 37285135
[TBL] [Abstract] [Full Text] [Related]
3. skin Aging in Long-Lived Naked Mole-Rats Is Accompanied by Increased Expression of Longevity-Associated and Tumor Suppressor Genes.
Fatima I; Chen G; Botchkareva NV; Sharov AA; Thornton D; Wilkinson HN; Hardman MJ; Grutzkau A; Pedro de Magalhaes J; Seluanov A; Smith ESJ; Gorbunova V; Mardaryev AN; Faulkes CG; Botchkarev VA
J Invest Dermatol; 2022 Nov; 142(11):2853-2863.e4. PubMed ID: 35691364
[TBL] [Abstract] [Full Text] [Related]
4. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
Stubbins RJ; Korotev S; Godley LA
Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
[TBL] [Abstract] [Full Text] [Related]
5. The prevalence of nonmelanoma skin cancer in a population of patients with oculocutaneous albinism in Haiti.
Hassan S; Louis SJ; Fethiere M; Dure D; Rosen J; Morrison BW
Int J Dermatol; 2022 Jul; 61(7):867-871. PubMed ID: 35393655
[TBL] [Abstract] [Full Text] [Related]
6. Angiokeratoma Circumscriptum Naeviforme Presenting as a Dark Warty Plaque on the Leg.
Abbenante D; Raone B; Baraldi C; Anna Carpanese M; Patrizi A
Acta Dermatovenerol Croat; 2021 Dec; 29(3):169-170. PubMed ID: 34990348
[TBL] [Abstract] [Full Text] [Related]
7. Discriminating Neoplastic from Nonneoplastic Tissues Using an miRNA-Based Deep cancer Classifier.
Kaczmarek E; Pyman B; Nanayakkara J; Tuschl T; Tyryshkin K; Renwick N; Mousavi P
Am J Pathol; 2022 Feb; 192(2):344-352. PubMed ID: 34774515
[TBL] [Abstract] [Full Text] [Related]
8. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
[TBL] [Abstract] [Full Text] [Related]
9. miR-21-5p promotes cell proliferation and G1/S transition in melanoma by targeting cdkn2c.
Yang Z; Liao B; Xiang X; Ke S
FEBS Open Bio; 2020 May; 10(5):752-760. PubMed ID: 32090490
[TBL] [Abstract] [Full Text] [Related]
10. Incremental Health Care Expenditure of Chronic Cutaneous Ulcers in the United States.
Tripathi R; Knusel KD; Ezaldein HH; Honaker JS; Bordeaux JS; Scott JF
JAMA Dermatol; 2019 Jun; 155(6):694-699. PubMed ID: 30892572
[TBL] [Abstract] [Full Text] [Related]
11. Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.
Marx SJ; Goltzman D
J Bone Miner Res; 2019 Jan; 34(1):22-37. PubMed ID: 30536424
[TBL] [Abstract] [Full Text] [Related]
12. Design and Evaluation of Gemini Surfactant-Based Lipoplexes Modified with Cell-Binding Peptide for Targeted Gene Therapy in Melanoma Model.
Mohammed-Saeid W; Soudy R; Tikoo R; Kaur K; Verrall RE; Badea I
J Pharm Pharm Sci; 2018; 21(1):363-375. PubMed ID: 30266136
[TBL] [Abstract] [Full Text] [Related]
13. Eccrine Duct Dilation as a Marker of Cicatricial Alopecia.
Tan T; Guitart J; Gerami P; Yazdan P
Am J Dermatopathol; 2017 Sep; 39(9):668-671. PubMed ID: 27673387
[TBL] [Abstract] [Full Text] [Related]
14. Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics.
Cohen PR; Tomson BN; Elkin SK; Marchlik E; Carter JL; Kurzrock R
Oncotarget; 2016 Apr; 7(17):23454-67. PubMed ID: 26981779
[TBL] [Abstract] [Full Text] [Related]
15. Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas.
Chen T; Fallah M; Försti A; Kharazmi E; Sundquist K; Hemminki K
JAMA Dermatol; 2015 Jun; 151(6):607-15. PubMed ID: 25671687
[TBL] [Abstract] [Full Text] [Related]
16. Pathologic complete response to intralesional interleukin-2 therapy associated with improved survival in melanoma patients with in-transit disease.
Hassan S; Petrella TM; Zhang T; Kamel-Reid S; Nordio F; Baccarelli A; Sade S; Naert K; Habeeb AA; Ghazarian D; Wright FC
Ann Surg Oncol; 2015; 22(6):1950-8. PubMed ID: 25366584
[TBL] [Abstract] [Full Text] [Related]
17. Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association?
Erdas E; Aste N; Pilloni L; Nicolosi A; Licheri S; Cappai A; Mastinu M; Cetani F; Pardi E; Mariotti S; Pomata M
BMC Cancer; 2012 Dec; 12():614. PubMed ID: 23259638
[TBL] [Abstract] [Full Text] [Related]
18. High-throughput sequencing of the melanoma genome.
Kunz M; Dannemann M; Kelso J
Exp Dermatol; 2013 Jan; 22(1):10-7. PubMed ID: 23174022
[TBL] [Abstract] [Full Text] [Related]
19. Dual suppression of the cyclin-dependent kinase inhibitors cdkn2c and CDKN1A in human melanoma.
Jalili A; Wagner C; Pashenkov M; Pathria G; Mertz KD; Widlund HR; Lupien M; Brunet JP; Golub TR; Stingl G; Fisher DE; Ramaswamy S; Wagner SN
J Natl Cancer Inst; 2012 Nov; 104(21):1673-9. PubMed ID: 22997239
[TBL] [Abstract] [Full Text] [Related]
20. Beyond BRAF in melanoma.
Daud A; Bastian BC
Curr Top Microbiol Immunol; 2012; 355():99-117. PubMed ID: 21826607
[TBL] [Abstract] [Full Text] [Related]
[Next]
